Serratia marcescens endocarditis treated with ceftazidime. A case report.
A 14-year-old Black girl developed Serratia marcescens endocarditis following a mitral valve repair. This was refractory to treatment with several courses of antibiotics and valve replacement, and was eventually cured after a second valve replacement and treatment with ceftazidime (GR 20263 Glaxo), a new cephalosporin derivative.